Tizanidine Tablet
Product Images NDC 57664-503

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 57664-503). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tizanidine-1 (Tizanidine 1)

Chemical structure diagram of Tizanidine Hydrochloride, showing its molecular skeleton with chlorine, sulfur, nitrogen atoms, and imidazoline ring components.*

FDA Label Image

Tizanidine-2 (Tizanidine 2)

A line graph depicting plasma tizanidine concentration (ng/mL) over time (hours from dosing) for 4 mg tizanidine tablets and capsules, both with and without food. The graph shows concentration peaking within the first few hours and declining thereafter, with separate lines for each condition labeled in the legend.*

FDA Label Image

Tizanidine-3 (Tizanidine 3)

Line graph showing improvement in Ashworth Score over hours post-dose comparing 16 mg tizanidine, 8 mg tizanidine, and placebo. The x-axis represents hours post-dose (0 to 6) and the y-axis shows improvement in Ashworth Score, with data points and error bars for each treatment group.*

FDA Label Image

Tizanidine-4 (Tizanidine 4)

A line plot comparing the improvement in Ashworth Score between Tizanidine at a mean dose of 28.8 mg and placebo over three time points: End of Titration (Study Week 3), End of Maintenance (Study Week 7), and Endpoint (Last Observation Carried Forward). The y-axis represents improvement with lower values indicating greater improvement, showing greater improvement for the Tizanidine group across all time points.*

FDA Label Image

Tizanidine-5 (Tizanidine 5)

Label for Tizanidine Tablets, USP 2 mg, oral tablets. The label includes storage instructions, a warning that Tizanidine tablets are not interchangeable with capsules, and states a container count of 150 tablets. The product is manufactured by Alkaloida Chemical Company Zrt. in Hungary and distributed by Sun Pharmaceutical Industries, Inc.*

FDA Label Image

Tizanidine-6 (Tizanidine 6)

Label for Tizanidine Tablets USP 4 mg, oral tablets supplied in a container of 150 tablets. The label states the tablets contain 4.576 mg tizanidine HCl equivalent to 4 mg tizanidine base. It includes storage instructions at 25°C, and a warning that tizanidine tablets are not interchangeable with capsules. Manufactured by Alkaloida Chemical Company Zrt., Hungary, and distributed by Sun Pharmaceutical Industries, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.